Hold Navin Fluorine Ltd For Target Rs.4520 - ICICI Direct
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Non legacy business to lead show…
About the stock: Navin Fluorine (NFIL) operates one of the largest integrated fluorochemicals complexes in India with a presence in speciality chemicals, CRAMS, inorganic fluoride and refrigerant segments
The company has two manufacturing facilities in Surat and Dewas while it is setting up a new greenfield capacity at Dahej
In terms of revenue contribution, speciality chemical constitutes 40% of overall revenue followed by CRAMS of 25% and the rest from refrigerant (~18%) and inorganic fluoride (~17%) businesses
Q1FY22 Results:Numbers were above our estimates across all parameters, led by strong growth from speciality chemical, inorganic fluoride and refrigerants.
Reported revenue growth was 23% YoY to | 379 crore, led by speciality chemical (up 25% YoY), inorganic fluoride (up 46% YoY) and refrigerants (up 53% YoY
Gross margins were up 170 bps YoY to 55.6% while EBITDA margin was up 40 bps YoY to 26%, due to higher operating cost such as employee (up 30% YoY) and other cost (up 28% YoY)
EBITDA was up 24% YoY to | 98.6 crore
PAT increased 17% YoY to | 68.8 crore
What should investors do?
The stock appreciated at 85% CAGR in last three years
We retain HOLD rating on the back of better growth outlook from value added segments such as CRAMS and speciality chemical
Target Price and Valuation: We value Navin Fluorine at 45x P/E FY24E EPS to arrive at a target price of | 4520/share (earlier | 3710/share).
Key triggers for future price performance:
Upcoming capex for speciality chemical and HPP to aid value added business revenue mix and thereby group return ratios
Potential entry into other key segments of fluorine molecules
Increase in custom synthesis/CRAMS business revenue
Alternate Stock Idea:
Apart from Navin Fluorine, in our chemical coverage, we also like Neogen Chemical
Trigger for Neogen Chemical’s future revenue growth would be increasing CRAMS opportunity
BUY with a target price of | 2160
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
Above views are of the author and not of the website kindly read disclaimer
